ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/c5NdLq0
No comments:
Post a Comment